4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-049681
President and CEO sold 29,022 shares at an average $20.43 ($592,812)
- President and CEO acquired 29,022 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fordyce Marshall · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-09 | Exercise or conversion : show line 1 in the form | +12,886 | $2.90 | $37,328 | 194,036 | D |
| 2022-09-09 | Sale : show line 2 in the form | −12,886 | $20.16 | $259,771 | 181,150 | D |
| 2022-09-12 | Exercise or conversion : show line 3 in the form | +12,821 | $2.90 | $37,140 | 193,971 | D |
| 2022-09-12 | Sale : show line 4 in the form | −12,821 | $20.53 | $263,195 | 181,150 | D |
| 2022-09-12 | Exercise or conversion : show line 5 in the form | +3,315 | $2.90 | $9,603 | 184,465 | D |
| 2022-09-12 | Sale : show line 6 in the form | −3,315 | $21.07 | $69,846 | 181,150 | D |
| Open-market sales · 29,022 sh · avg $20.43 · $592,812 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-09 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −12,886 | 1,017,711 | D |
| 2022-09-12 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −16,136 | 1,001,575 | D |
Loading xslF345X03/doc4.xml…